MolMed festeggia in Borsa: Germania conferma rimborsabilità Zalmoxis®
Orchard Therapeutics and MolMed Announce Extension of Gene Therapy Manufacturing Collaboration
Will MolMed soon have its first Cell therapy on the Market?
PROSPETTO INFORMATIVO MolMed S.p.A.
Molmed, Opa dei giapponesi di Agc. Per Berlusconi 30 milioni di plusvalenza - Affaritaliani.it
Half-Year Financial Report at June 30th, 2020
MolMed - YouTube
MOLMED S.P.A.: MLM Azione Prezzo| IT0001080248 | MarketScreener
IPO | molmed
Prezzi da saldo a Piazza Affari, rischio Opa straniere. Giapponesi su MolMed
Relazione sulla Remunerazione MolMed S.p.A.
MolMed to test the health of the European sector | Evaluate
Meeting agenda | molmed
MOLMED S.P.A. : MLM Stock Price | IT0001080248 | MarketScreener
MolMed non vuole il golden power: «Offerta Agc conveniente per tutti» - Il Sole 24 ORE
Molmed, opa della giapponese Agc per la biotech italiana Molmed - Wired | Wired Italia
1 - [Note: this notice is the English translation of the official version of the 102 notice which will be in Italian language]
MolMed now part of AGC Biologics | LinkedIn
MolMed, Fininvest aderisce all'OPA e cede quota 23,1%
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHER
MolMed now part of AGC Biologics | LinkedIn
Small Cap Conference 2013: listed SMEs meet investors at Borsa Italiana
COVID-19 impacting Cell&Gene therapy manufacturing Webinar | molmed
